Company intelligence / Profile preview

Avoro Ventures

New York City, New York, United States
Ownership
Private
Development stage
Other
01

Overview

Avoro Ventures supports innovative early-stage and growth-stage life sciences and biotech companies, with investments across drug discovery, therapeutic platforms, and healthtech tools. Not a clinical-stage company itself.

Therapeutic areas
Rare DiseasesHematologyDermatologyCardiovascularOncologyNeurology
Modalities
Small moleculeMonoclonal antibodyGene therapyRNA therapy
Industry
Investors
02

Partnerships

invests alongside major funds, biopharma, and strategic investorssome partnered co-investments with big pharma

Beyond the preview

Go deeper on Avoro Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avoro Ventures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call